230 related articles for article (PubMed ID: 32329875)
1. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
[TBL] [Abstract][Full Text] [Related]
3. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
[TBL] [Abstract][Full Text] [Related]
4. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
6. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
[TBL] [Abstract][Full Text] [Related]
7. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of troponin I elevation after elective percutaneous coronary intervention.
Auguadro C; Scalise F; Manfredi M; Casali V; Novelli E; Specchia G
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):149-55. PubMed ID: 25010505
[TBL] [Abstract][Full Text] [Related]
10. Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions.
Lupi A; Rognoni A; Lazzero M; Rolla R; Pergolini P; Bellomo G; Rossi L; Sante Bongo A; Jaffe AS
EuroIntervention; 2016 Mar; 11(12):1380-8. PubMed ID: 25405803
[TBL] [Abstract][Full Text] [Related]
11. Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
Dautov R; Ybarra LF; Nguyen CM; Gibrat C; Joyal D; Rinfret S
Catheter Cardiovasc Interv; 2018 Nov; 92(5):E308-E316. PubMed ID: 29481724
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
14. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.
Nageh T; Sherwood RA; Harris BM; Thomas MR
Heart; 2005 Sep; 91(9):1181-5. PubMed ID: 16103554
[TBL] [Abstract][Full Text] [Related]
16. Cardiac troponin I for risk stratification following percutaneous coronary artery intervention in acute coronary syndromes.
Nageh T; Sherwood RA; Harris BM; Thomas MR
Catheter Cardiovasc Interv; 2002 Jan; 55(1):37-42. PubMed ID: 11793493
[TBL] [Abstract][Full Text] [Related]
17. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
[TBL] [Abstract][Full Text] [Related]
18. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
[TBL] [Abstract][Full Text] [Related]
19. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
[TBL] [Abstract][Full Text] [Related]
20. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
